Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
JinkoSolar's Subsidiary, Jinko Solar Co., Ltd., Announces Half Year 2025 Unaudited Financial Results
-
One Hemp Thanks Representative Morgan Griffith for Leadership on Draft Hemp Legislation and Calls for Balanced Federal Oversight
-
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
-
Shentel Brings Fiber-to-the-Home Internet to Radford, VA
-
Data Watts Partners with Trusted Financial to Accelerate Investment in the Data Watts Economy
-
Delta Resources Announces Phase II of 2025 Drill Program in Thunder Bay, Ontario
-
Drilling Underway at Pacific Ridge's Kliyul Copper-Gold Project
-
C3 Metals Awards Maiden Drill Contract at Khaleesi Copper-Gold Project, Peru
-
Pet Valu Locks in Lower Prices on Over 100 Pet Products
-
Robo.ai Inc. Appoints Seasoned Global Executive as Chief Legal and Compliance Officer
-
Invivyd to Participate in Upcoming Investor Conferences
-
Intellum and Honorlock Partner to Elevate Assessment Integrity with AI-Enhanced Proctoring
-
HARVEST MIDSTREAM ACCELERATES EXPANSION WITH $1 BILLION ACQUISITION OF MPLX UINTA AND GREEN RIVER BASIN GAS GATHERING & PROCESSING ASSETS
-
Garmin unveils the Blaze equine wellness system
-
Housecall Pro celebrates successful Pro Pit Stop event in Tampa
-
‘The Logic of Psychology’ 2nd Edition Unveils a Bold New Framework for Understanding the Human Mind
-
Mooresville Ford Hosts ‘Justin’s Wish’ Celebration in Support of Make-A-Wish
-
Panzura CloudFS Reimagines File Data Defense with New AI-Powered Threat Control
-
Western Communities Foundation Opens 2025 Grant Applications to Build Safer, Stronger Communities
-
FirstTeam Real Estate Launches Flex with Notable to Give Sellers a Competitive Edge
-
Northstar Reports Second Quarter 2025 Financial and Operating Results and Announces Upcoming Investor Conference Call
-
Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
-
TONIES® INTRODUCES NEW TONIEBOX 2, TONIEPLAY AND MY FIRST TONIES
-
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
-
U.S. GoldMining Advances 2025 Exploration Program Targeting Continued Growth at the District Scale Whistler Gold-Copper Project, Alaska
-
Skye Bioscience to Host Virtual KOL Event and Provide Perspectives on Upcoming CBeyond™ Phase 2a Topline Clinical Data Readout
-
MPLX LP to Divest Rockies Gathering and Processing Assets
-
From Wellness to Addiction: Troy Rafferty's New Article Sounds Alarm on 'Feel Free'
-
Mexican Avocado Industry Leads with First Zero-Deforestation Agreement
-
Adcendo ApS to Participate in Upcoming September Investor Conferences
-
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025
-
Keeper Security Launches KeeperAI to Deliver Real-Time Detection and Defense Against Cyber Threats
-
The J.M. Smucker Co. Announces Fiscal 2026 First Quarter Results
-
Wugen Secures $115 Million to Advance Pivotal Study of First-in-Class Allogeneic CAR-T Therapy, WU-CART-007
-
Copper Cane Wines & Spirits Introduces New California Cabernet Sauvignon and California Rosé to Threadcount Portfolio
-
DOLLARAMA REPORTS FISCAL 2026 SECOND QUARTER RESULTS
-
OBSBOT Powers EWC 2025 in Riyadh with AI-Driven 4K Videography and Scalable Live Production
-
Suunto Introduces Race 2 and Wing 2
-
Antiva Biosciences Announces Positive Top-Line Results from Phase 1b/2 Study of ABI-2280 for Treatment of Cervical High-Risk Human Papillomavirus (hrHPV) Infection
-
Indigenized Energy Warns of Human and Climate Costs After EPA Terminates $7 Billion Solar Program
-
Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference
-
Groundbreaking Project Analyzes Cell Phone Data from Individuals who Died by Suicide Revealing Unprecedented Insights
-
CancerLinQ Receives ASCO Certified™ RQS Recognition Enabling Automated Quality Tracking That Helps Oncology Care Practices Save Critical Time and Resources
-
Kohl's Reports Second Quarter Fiscal 2025 Financial Results
-
Ocular Therapeutix™ to Participate in September Investor and Scientific Conferences
-
mPulse Acquires Clarity Software Solutions to Advance its Leadership in the Health Experience and Insights (HXI) Category
-
Bio-Techne to Present at Upcoming Investor Conferences
-
Verastem Oncology to Present at Upcoming Investor Conferences
-
Prosegur Security Appoints Jose G. Rivero as Senior Vice President to Lead Expanding Technology Division
-
Zemcelpro® (UM171 Cell Therapy) receives EC authorization as the first and only cell therapy for blood cancer patients without access to suitable donor cells

